United States· US:55513-842_0e9f4d69-138c-4098-93b3-527229f49acd
AIMOVIG
A erenumab product containing erenumab, registered in United States by Amgen Inc. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Erenumab is registered in 13 of 19 countries.
Countries holding a registration under ATC N02CD01 (erenumab), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Erenumab · ATC N02CD01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ERENUMAB
- Manufacturer
- Amgen Inc
- Country
- United States (US)
- ATC code
- N02CD01
- ATC class
- Erenumab
- Defined daily dose
- 2.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 12, 2026
Packs & prices · 2
- ndc1155513842011 SYRINGE in 1 CARTON (55513-842-01) / 1 mL in 1 SYRINGE
- ndc1155513-842-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erenumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAimovigNovartis Europharm Limited
- CzechiaAIMOVIGNovartis Europharm Limited, Dublin
- BelgiumAimovig 140 mgNovartis Europharm
- IcelandAimovigNovartis Europharm Limited*
- NetherlandsAimovig 140 mg oplossing voor injectie in voorgevulde penNovartis Europharm Limited
- SwedenAimovig 140 mg Injektionsvätska, lösning i förfylld injektionspennaNovartis Europharm Limited
- SpainAIMOVIG 140 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADANovartis Europharm Limited
- NorwayAimovigNovartis Europharm Limited (1)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aimovig
- Liechtenstein · Aimovig
- Norway · Aimovig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/45f1ddb8-9a0f-4caa-9518-188e3e9ec289 GET /v1/drugs/45f1ddb8-9a0f-4caa-9518-188e3e9ec289?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "140",
"substance": "ERENUMAB",
"productndc": "55513-842",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761077",
"marketing_category": "BLA"
}See everything about erenumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.